1[1]Pessin J E, Saltiel A R. Signalling Pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 2000;106:165 - 169.
2[2]Kawamura T, Egusa G, Okubo M, et al. Association of receptor gene polymorphism with insulin sesistance in JapaneseAmerican men. Metabolism 1999; 11:1367 - 1370.
3[3]Benecke H, Topak H, von Zur Muhlen A, et al. A study on the genetics of obesity:influence of polymorphisms of the beta - 3-abrenergic receptor and insulin receptor substrate 1 in relation to weight loss, waist to receptor hip ratio and Frequencies of common cardiovascular risk factors. Exp Clin Endocrinol Diabetes2000; 108: 86 - 92.
4[4]Buettner R, Scholmerich J, Palitzsch K D, et al, The Trp64Polymorphism of the β3 - adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large populataionbased Caucasion cohort. J Clin Endocrinol Metab 1998;83:2892- 2897.
5[5]Timothy J T J, Kieffer R S, Holler C A, et al, Leptin supperession of insulin secretion by the actiovation of ATP-sensitive K+ channes in pancreatic β-cells. Diabetes 1997; 46:1087-1093.
6[6]Hafmann C et al. Altered gene expression for TNF-a and its receptors during drug and dietary modulation of insulin resistance. Endocrindogy 1994;134:264.
7[7]Hotamisligil G S et al, Increased tissue expression of TNFa in human obesity and insulin resistance, J Clin Invest 1995;2049.
8[8]Saghizaedh M et al, The expression of TNF-a by human musce relation shiop to insulin resistance. J Clin Invest 1996;97:1111.
9[9]kern pA, et al. The expression of TNF-a in human adipose tissue regulation by obesity, weight loss and relationshiop to lipoprotein lipase J Clin Invest 1995;95:2111.
10[10]Hotmisligil G S et al. IRS-1-mediated inhibition of insulin recepor tyrsine kinase activity in tumor necorsis factor-a and obesity -induced insulin resistance. Seience 1996; 271: 665.
